🏅 FDA Orphan Designation
Pirfenidone Capsule, 267 Mg
PIRFENIDONE CAPSULE, 267 MG
Manufacturer: Macleods Pharmaceuticals Limited
Indicated for:
FDA-Approved Indications (1)
Pirfenidone capsules are indicated for the treatment of idiopathic pulmonary fibrosis (IPF)
Population: all ages
Indications & Usage
1 INDICATIONS AND USAGE Pirfenidone capsules are indicated for the treatment of idiopathic pulmonary fibrosis (IPF). Pirfenidone capsules are a pyridone indicated for the treatment of idiopathic pulmonary fibrosis (IPF). ( 1 )
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.